Pfizer Inc closed the trading session at $28.37, slipping 0.11% as the stock faced modest downward pressure throughout the day. After opening lower, shares fluctuated between a low of $27.94 and a high of $28.80, reflecting a day characterized by cautious trading amid broader market sentiments.
The S&P 500 edged down 0.01% to close at $778.01, while the Dow Jones Industrial Average slipped 0.33% to finish at $516.21. In the pharmaceutical sector, Pfizer’s performance diverged from its competitors, with Eli Lilly (LLY) declining 1.36% to $1,166.51 and Johnson & Johnson (JNJ) experiencing a sharper slide of 5.73% to $248.61. This relative strength may suggest a degree of resilience in Pfizer’s stock amid sector-wide pressures affecting its peers.
Positioned within a 52-week trading range of $23.62 to $29.21, Pfizer is currently 2.9% below its yearly high of $29.21. The stock’s trading volume reached 31.33 million shares, indicating robust interest as the market navigated through volatile conditions. This level of activity may reflect profit-taking behavior as traders reassess positions following recent gains, with the stock finding a foothold just beneath key resistance levels.